Jun 5-8 2023
We’re having great discussions at International Convention !! BIO2023
INOVOTION is meeting with pharma, biotech and academic representatives for deep discussions around our highly efficient and affordable preclinical assays using our chicken embryo (CAM) model. It’s a true in vivo model that is 3Rs-compliant, fast, and cost-saving. Inovotion has carried out anti-tumor efficacy studies for all types of cancers and drugs including IO.
We can help you achieve your projects quickly, reliably, and cost-effectively.
Our CEO Jean Viallet and Business developer Candice Chrétien are available for discussion at the European Pavilion in Hall B, Booth C-1911.
BIO2023#StandUpForScience Immunology Cancer Oncology EUeic EUatBIO2023